迈普医学 (301033)

Medprin Regenerative Medical Technologies Co.,Ltd.

ASZ

Tags

3D PrintingMedical DevicesMedical Aesthetics ConceptPlanned Reduction of HoldingsPrivate Equity Heavy PositionsHigh-Performing StocksShareholder ReductionRestructuring ProposalsStable Growth IndexAdvantageous Growth IndexSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexJuly 2022 Lock-up ExpiryInternal Employee SharesShareholding Increase CommitmentManufacturing IndexChina United Quality Growth IndexGuangdong

K-Line Chart

No K-line data available

Company NameMedprin Regenerative Medical Technologies Co., Ltd.
Listing Date2021-07-26
Issue Price15.14RMB
Registered Capital6704.96210k RMB
Legal RepresentativeYuan Yuyu
Registered AddressNo. 3, Yaying Shi Road, Huangpu District, Guangzhou City, Guangdong Province
IndustryMedical Devices
Main BusinessThe company is a high-tech enterprise dedicated to developing high-performance implantable medical devices by combining the characteristics of synthetic materials and utilizing advanced manufacturing technologies.
Company ProfileMedprin Regenerative Medical Technologies Co., Ltd. was established in September 2008. The company is a high-tech enterprise dedicated to developing high-performance implantable medical devices by combining the characteristics of synthetic materials and utilizing advanced manufacturing technologies. The company is the only domestic enterprise in the field of neurosurgery that simultaneously possesses implantable medical device products such as artificial dura mater (spinal) patches, craniomaxillofacial repair products, and absorbable hemostatic gauze, covering the key implantable medical devices required for craniotomy surgeries. Meanwhile, adhering to clinical needs as the guidance, the company fully leverages the advantages of multiple technology platforms, including biological additive manufacturing, to expand product applications to multiple departments. It is committed to becoming a global leader in the field of implantable medical devices, providing excellent products and serving patients worldwide. To date, the company has obtained approval for the registration of 4 Class III and 1 Class II medical device products, filed 1 Class I medical device product, and acquired CE certificates and CE Design certificates for 3 products. It has 9 products under research and development, laying a foundation for sustaining future business performance growth.

Stock Details

1. Key Indicators

  • Total Shares(W): 6704.96
  • Circulating A-Shares(W): 5646.91
  • Earnings Per Share(RMB): 1.1500
  • Net Assets Per Share(RMB): 11.2798
  • Operating Revenue(W RMB): 24922.82
  • Total Profit(W RMB): 8777.88
  • Net Profit Attributable to Parent(W RMB): 7585.40
  • Net Profit Growth Rate(%): 43.65
  • Weighted Return on Equity(%): 10.4300
  • Operating Cash Flow Per Share(RMB): 1.2570
  • Undistributed Profit Per Share(RMB): 2.9177
  • Capital Reserve Per Share(RMB): 7.1955

2. Main Business

The main business covers:

  • Developing high-performance implantable medical devices by combining the characteristics of artificial synthetic materials with advanced manufacturing technologies.

3. Company Basic Information

  • Company Name: Medprin Regenerative Medical Technologies Co., Ltd.
  • Listing Date: 2021-07-26
  • Industry: Special Purpose Equipment Manufacturing
  • Address: No. 3 Yaying Shi Road, Huangpu District, Guangzhou City, Guangdong Province
  • Website: www.medprin.com
  • Company Profile: Medprin Medical was established as a joint stock company through the overall transformation of Medprin Medical Co., Ltd. On June 1, 2018, the shareholders of Medprin Medical Co., Ltd. resolved to change the company into a joint stock company with all shareholders as promoters.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shenzhen Kaiying Technology Co., Ltd. General Legal Person 405.31 7.23
2 Beijing Fengyan Investment Management Co., Ltd. - Beijing Fengyan Ruiying No. 3 Private Securities Investment Fund Private Securities Investment Fund 380.00 6.78
3 Huatai Securities Asset Management - China Merchants Bank - Huatai Maipu Medical Home No. 1 ChiNext Employee Shareholding Collective Asset Management Plan General Legal Person 165.16 2.95
4 Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. - Xuanyuan Kexin No. 293 Private Securities Investment Fund Private Securities Investment Fund 164.20 2.93
5 Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) General Legal Person 127.19 2.27
6 Guotai Jiatai Stock Special Pension Product - China Merchants Bank Co., Ltd. Asset Management Plan 98.32 1.75
7 Dacheng Value Growth Securities Investment Fund Class A Fund 82.17 1.47
8 Guotai Value Pioneer Stock Securities Investment Fund Class A Fund 50.65 0.90
9 Dacheng Positive Growth Hybrid Securities Investment Fund Class A Fund 39.65 0.71
10 Dacheng ChiNext Two-Year Regular Open Hybrid Securities Investment Fund Class A Fund 34.79 0.62

5. Concept Sectors

  • 3D Printing
  • Medical Aesthetics Concept
  • Margin Trading & Securities Lending
  • High-Performance Stock
  • Shareholder Reduction
  • Restructuring Plan
  • Intended Reduction
  • Private Placement Heavy Position

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information